96 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
of such person’s own fraud or bad faith.
Amendment of Awards. Except as otherwise provided under the Amended Plan with respect to repricing outstanding stock … approval) arising out of any act or omission to act concerning the Plan unless arising out of such person’s own fraud or bad faith.
(h) Governing Law
8-K
EX-1.1
cdkl2izbmzp0ud zkb2
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
D
sitfylrp0wjrff8pcs
21 Sep 22
$129.84M in equity / options, sold $129.84M, 19 investors
5:07pm
425
nfbrfes609q61e47v4
15 Sep 22
Business combination disclosure
4:08pm
8-K
EX-99.1
01l 5hs577zoq6
15 Sep 22
Departure of Directors or Certain Officers
4:06pm